300937SZSE

Announcement on Engaging the Company's 2026 Audit Firm

Yao Yi Gou Co., Ltd.··5 pages

✨ AI Summary

Sichuan Zongzong Pharmaceutical Co., Ltd. announces its intention to appoint Sichuan Huaxin (Group) Certified Public Accountants (Special General Partnership) as its 2026 financial and internal control auditor, replacing Xinyong Zhonghe. The change is due to business development and audit needs. The proposal has been approved by the board and will be submitted to the shareholders' meeting.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Securities Code: 300937

Securities Abbreviation: Yaoyigou

Announcement Number: 2026-035

Sichuan Zongzong Pharmaceutical Co., Ltd.

Announcement on Engaging the Company's 2026 Audit Firm

The company and the entire board of directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.

Special Notice:

  1. Name of the proposed accounting firm: Sichuan Huaxin (Group) Certified Public Accountants (Special General Partnership) (hereinafter referred to as "Sichuan Huaxin")

  2. Name of the previously engaged accounting firm: Xinyong Zhonghe Certified Public Accountants (Special General Partnership) (hereinafter referred to as "Xinyong Zhonghe")

  3. Reason for changing the accounting firm: Considering the company's business development, audit work requirements, and accounting firm personnel arrangements and work plans, in accordance with the "Administrative Measures for the Selection of Accounting Firms by State-owned Enterprises and Listed Companies," the company proposes to appoint Sichuan Huaxin as the financial audit institution and internal control audit institution for 2026 (hereinafter referred to as the "2026 Audit Institution"), with a term of one year. The company has fully communicated with the previous and current accounting firms on this matter, and all parties have confirmed and have no objections.

  4. The proposed appointment of Sichuan Huaxin as the company's 2026 audit institution complies with the relevant provisions of the "Administrative Measures for the Selection of Accounting Firms by State-owned Enterprises and Listed Companies."

Sichuan Zongzong Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held the ninth meeting of the fourth board of directors on August 10, 2026, and deliberated and passed the "Proposal on Engaging the Company's 2026 Audit Institution." It was agreed to appoint Sichuan Huaxin as the company's 2026 audit institution for a term of one year. This proposal needs to be submitted to the company's shareholders' meeting for deliberation. The relevant matters are hereby announced as follows:

I. Basic Information of the Proposed Accounting Firm

(I) Firm Information

  1. Basic Information

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.